Prognostic Impact of MYH9 Expression on Patients with Acute Myeloid Leukemia
Mengxia Yu,Jinghan Wang,Zhijuan Zhu,Chao Hu,Qiuling Ma,Xia Li,Xiufeng Yin,Jiansong Huang,Ting Zhang,Zhixin Ma,Yile Zhou,Chenying Li,Feifei Chen,Jian Chen,Yungui Wang,Hanzhang Pan,Dongmei Wang,Jie Jin
DOI: https://doi.org/10.18632/oncotarget.10613
2016-01-01
Oncotarget
Abstract:MYH9 expression has previously been demonstrated as an independent predictor of clinical outcome in solid tumors. However, the prognostic relevance of MYH9 expression in acute myeloid leukemia is still unclear. Here, we found high MYH9 expressers were seen more frequently in females and more frequently in M4 morphology. We also found high MYH9 expressers had lower percentage of bone marrow blasts. In addition, overexpression of MYH9 was associated with an inferior overall survival. Notably, distinct microRNA signatures were seen in high MYH9 expressers. These results were also validated in an independent cohort of AML patients using the published data. In conclusion, gene of MYH9 expression might serve as a reliable predictor for overall survival in AML patients.